Literature DB >> 20921478

How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement.

Steven D Pearson1, Peter B Bach.   

Abstract

Medicare must find new ways to achieve cost control without limiting access to beneficial services. We propose a payment model incorporating comparative effectiveness research to encourage Medicare to pay equally for services that provide comparable patient outcomes. The model would include higher payments for services demonstrated by adequate evidence to provide superior health benefits compared to alternative options. New services without such evidence would receive usual reimbursement rates for a limited time but then be reevaluated as evidence emerged. In spite of the substantial political hurdles to changing Medicare reimbursement, efforts should be made to use comparative effectiveness research to reward superior services, improve incentives for cost-effective innovation, and place Medicare on a more sustainable financial footing.

Entities:  

Mesh:

Year:  2010        PMID: 20921478     DOI: 10.1377/hlthaff.2010.0623

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  17 in total

1.  Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines?

Authors:  Ethan Basch; Mark R Somerfield; Ann Partridge; Lowell Schnipper; Gary H Lyman
Journal:  J Oncol Pract       Date:  2011-10-18       Impact factor: 3.840

2.  Preparing for success with comparative effectiveness research.

Authors:  Thomas G Roberts
Journal:  Oncologist       Date:  2013-06

3.  The end of hospital cost shifting and the quest for hospital productivity.

Authors:  Austin B Frakt
Journal:  Health Serv Res       Date:  2013-09-16       Impact factor: 3.402

4.  Cervical cancer screening in the United States and the Netherlands: a tale of two countries.

Authors:  Dik Habbema; Inge M C M De Kok; Martin L Brown
Journal:  Milbank Q       Date:  2012-03       Impact factor: 4.911

Review 5.  Cost, coverage, and comparative effectiveness research: the critical issues for oncology.

Authors:  Steven D Pearson
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

6.  Brief history of quality movement in US healthcare.

Authors:  Youssra Marjoua; Kevin J Bozic
Journal:  Curr Rev Musculoskelet Med       Date:  2012-12

7.  Principles and reality of proton therapy treatment allocation.

Authors:  Justin E Bekelman; David A Asch; Zelig Tochner; Joseph Friedberg; David J Vaughn; Ellen Rash; Kevin Raksowski; Stephen M Hahn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-03       Impact factor: 7.038

8.  Reference pricing with evidence development: a way forward for proton therapy.

Authors:  Justin E Bekelman; Stephen M Hahn
Journal:  J Clin Oncol       Date:  2014-04-21       Impact factor: 44.544

9.  Bending the cost curve in cancer care.

Authors:  Thomas J Smith; Bruce E Hillner
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

10.  Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report.

Authors:  Jerry A Krishnan; Peter K Lindenauer; David H Au; Shannon S Carson; Todd A Lee; Mary Ann McBurnie; Edward T Naureckas; William M Vollmer; Richard A Mularski
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.